✦ LIBER ✦

A randomised study of the effects of letrozole and anastrozole on oestrogen receptor positive breast cancers in postmenopausal women

✍ Scribed by J. Murray; O. E. Young; L. Renshaw; S. White; L. Williams; D. B. Evans; J. St. J. Thomas; M. Dowsett; J. M. Dixon

Publisher: Springer US
Year: 2008
Tongue: English
Weight: 173 KB
Volume: 114
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-008-0027-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A study of the effects of the aromatase

A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer

✍ Fiona M. McCaig; Lorna Renshaw; Linda Williams; Oliver Young; Juliette Murray; E 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 286 KB

Effect of a switch of aromatase inhibito

Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study

✍ Karine Briot; Michèle Tubiana-Hulin; Laurent Bastit; Ioana Kloos; Christian Roux 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 260 KB

Cost-effectiveness of letrozole versus t

Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspective

✍ Thomas E. Delea; Khalid El-Ouagari; Jonathan Karnon; Oleg Sofrygin 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 301 KB

Effects of toremifene and anastrozole on

Effects of toremifene and anastrozole on serum lipids and bone metabolism in postmenopausal females with estrogen receptor–positive breast cancer: the results of a 2-year multicenter open randomized study

✍ Keisei Anan; Shoshu Mitsuyama; Yasuhiro Yanagita; Morihiko Kimura; Hiroyoshi Doi 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 250 KB

Comparison of anastrozole versus tamoxif

Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer : The pre-operative “Arimidex” compared to Tamoxifen (PROACT) trial

✍ Luigi Cataliotti; Aman U. Buzdar; Shinzaburo Noguchi; Jose Bines; Yuichi Takatsu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

## Abstract ## BACKGROUND The Pre‐Operative “Arimidex” Compared to Tamoxifen (PROACT) study was a randomized, multicenter study comparing anastrozole with tamoxifen as a preoperative treatment of postmenopausal women with large, operable (T2/3, N0‐2, M0), or potentially operable (T4b, N0‐2, M0) br

A randomized trial exploring the biomark

A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer

✍ O. C. Freedman; E. Amir; W. Hanna; H. Kahn; F. O’Malley; G. Dranitsaris; D. E. C 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 257 KB